Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents

由 Youdim, Moussa B. H.
出版 2010

Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline

由 Youdim, Moussa B.H.
出版 2013

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?

由 Youdim, Moussa B. H.
出版 2010

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

由 Youdim, Moussa B H, Bakhle, Y S
出版 2006

The neurochemical and behavioral effects of the novel cholinesterase–monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats

由 Sagi, Yotam, Driguès, Noam, Youdim, Moussa B H
出版 2005

Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid Activities

由 Zheng, Hailin, Youdim, Moussa B. H., Fridkin, Mati
出版 2010

Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline

由 Abassi, Zaid A, Binah, Ofer, Youdim, Moussa B H
出版 2004

Multifunctional drugs as neurotherapeutics

由 Van der Schyf, Cornelis J., Youdim, Moussa B. H.
發表在 Neurotherapeutics (2009)

Parkinson's disease and related disorders

由 Riederer, Peter., Reichmann, Heinz., Youdim, Moussa B. H., Gerlach, Manfred.
出版 2006

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

由 Youdim, Moussa B H, Gross, Aviva, Finberg, John P M
出版 2001

Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

由 Weinreb, Orly, Amit, Tamar, Mandel, Silvia, Youdim, Moussa B. H.
出版 2009

Neuroprotection and Neuroregeneration in Alzheimer's Disease

由 Sugaya, Kiminobu, Youdim, Moussa B. H., Nordberg, Agneta, Rao, K. S. Jagannatha
出版 2012

Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β‐amyloid in ageing and Alzheimer's disease

由 Weinreb, Orly, Amit, Tamar, Bar‐Am, Orit, Youdim, Moussa B H
發表在 Br J Pharmacol (2015)

A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A

由 Fishman-Jacob, Tali, Reznichenko, Lydia, Youdim, Moussa B. H., Mandel, Silvia A.
出版 2009

Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus

由 Mechlovich, Danit, Amit, Tamar, Bar-Am, Orit, Weinreb, Orly, Youdim, Moussa B H
發表在 Br J Pharmacol (2014)

Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases

由 Mandel, Silvia A., Amit, Tamar, Weinreb, Orly, Reznichenko, Lydia, Youdim, Moussa B. H.
發表在 CNS Neurosci Ther (2008)

Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases

由 Halperin, Ilan, Morelli, Micaela, Korczyn, Amos D., Youdim, Moussa B. H., Mandel, Silvia A.
發表在 Neurotherapeutics (2009)

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration

由 Lam, Chun-Sing, Li, Jing-Jie, Tipoe, George Lim, Youdim, Moussa B. H., Fung, Man-Lung
發表在 PLoS One (2017)

A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury

由 Xiao, Jia, Lv, Yi, Lin, Bin, Tipoe, George L., Youdim, Moussa B. H., Xing, Feiyue, Liu, Yingxia
發表在 Oxid Med Cell Longev (2015)

M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus

由 Lam, Chun-Sing, Tipoe, George Lim, Wong, Johnny Kong-Ching, Youdim, Moussa B. H., Fung, Man-Lung
發表在 PLoS One (2016)